U.S. Electric Utilities Stock News

NYSE:WTTR
NYSE:WTTREnergy Services

Is Select Water Solutions (WTTR) Pricing Reflect Recent Energy Sector Water Projects Accurately

If you are looking at Select Water Solutions and wondering whether the current price reflects its true worth, this article will walk through what the numbers are actually saying about the stock. The share price last closed at US$13.26, with returns of 4.2% over 7 days, 12.2% over 30 days, 19.6% year to date, 1.8% over 1 year, 79.7% over 3 years, and 120.8% over 5 years. This gives useful context before comparing that price to estimates of value. Recent news around Select Water Solutions has...
NYSE:AWK
NYSE:AWKWater Utilities

American Water Works Grant And New Leadership Put Valuation In Focus

American Water Works Company (NYSE:AWK) has launched its 2026 Water and Environment Grant Program, aiming to support clean water, conservation, and community-focused environmental projects. The company has also announced a key leadership appointment in its Southern California business, focused on business development and strengthening relationships with communities and stakeholders. Both steps reflect ongoing efforts around sustainability, community investment, and the growth of American...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

AeroVironment Hires Washington Leader As Shares Trade Below Analyst Targets

AeroVironment (NasdaqGS:AVAV) has appointed Stephen Voline as Senior Director of Washington Operations. Voline is an experienced defense and national security leader with a background in senior military roles and legislative strategy. His appointment is aimed at deepening AeroVironment’s engagement with Congress and key national security stakeholders. AeroVironment focuses on defense technology such as drones and autonomous systems, an area that is drawing increased government attention and...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Should Axon’s Cleaned-Up Balance Sheet and DHS Body-Camera Push Require Action From Axon (AXON) Investors?

Axon Enterprise recently retired all of its 0.50% convertible senior notes due 2027, redeeming US$840,000 in cash and settling a further US$80.27 million of conversions, while also benefiting from a Department of Homeland Security move to broaden the nationwide use of body-worn cameras. This combination of a cleaner capital structure and a federal push for expanded body-camera deployment underscores how Axon’s TASER, body camera, and cloud ecosystem is increasingly aligned with evolving...
NYSE:SCHW
NYSE:SCHWCapital Markets

Is Charles Schwab (SCHW) Attractively Priced After Recent Share Price Weakness

If you are wondering whether Charles Schwab is reasonably priced at its current level, this article walks through the numbers so you can judge the value for yourself. The stock last closed at US$93.08, with a 7 day return of 6.2% decline, a 30 day return of 10.3% decline, a year to date return of 8.4% decline, and a 1 year return of 15.6%, 3 year return of 21.7% and 5 year return of 58.6%. Recent headlines around Charles Schwab have focused on its role as a major US brokerage and bank, as...
NasdaqGS:IPGP
NasdaqGS:IPGPElectronic

Is It Too Late To Consider IPG Photonics (IPGP) After Its 110% One Year Surge?

If you are wondering whether IPG Photonics at around US$134.86 still offers value after a strong run, this article walks through what the current price might be implying. The stock has logged returns of 21.8% over the past week, 65.0% over 30 days, 80.2% year to date and 110.8% over 1 year, while the 3 year return is 6.9% and the 5 year return is a 41.1% decline. Recent attention on IPG Photonics has centered on its position in high power fiber lasers and its role as a supplier to industrial...
BATS:CBOE
BATS:CBOECapital Markets

Assessing Cboe Global Markets (CBOE) Valuation After Earnings Beat And Expanded Russell 2000 Options Trading

Cboe Global Markets (CBOE) is back in focus after reporting fourth quarter and full year 2025 results that topped analyst expectations and after rolling out nearly 24 hour trading for Russell 2000 index options. See our latest analysis for Cboe Global Markets. The recent 1-day share price return of 3.30% takes Cboe Global Markets to US$284.20. It now sits on an 11.76% 90-day share price return alongside a 5-year total shareholder return of 212.64%. This points to momentum that investors...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Assessing Astronics (ATRO) Valuation After Strong 1 Year And 90 Day Share Price Returns

Why Astronics Is On Investors’ Radar Today Astronics (ATRO) is drawing attention after recent price moves, with the stock last closing at US$76.97 and showing strong returns over the past year and past 3 months. See our latest analysis for Astronics. The recent 90 day share price return of 55.95% and very strong 1 year total shareholder return of 307.46% suggest momentum has been building, with shorter term moves reinforcing a much longer rebound story for Astronics. If Astronics’ move has...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Evaluating Critical Metals (CRML) Valuation After Sharp Share Price Pullback

Why Critical Metals is on investors’ radar Critical Metals (CRML) has attracted attention after a stretch of mixed share price moves, with a roughly 47% decline over the past month but a gain over the past 3 months. See our latest analysis for Critical Metals. At a share price of $9.33, Critical Metals has recently seen pressure, with a 7 day share price return showing a 15.18% decline and a 30 day share price return showing a 47.14% decline. Its 1 year total shareholder return of about 2.4x...
NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

CFO Retirement And Interim Successor Put Focus On MPWR Valuation And Margins

Monolithic Power Systems (NasdaqGS:MPWR) announced the retirement of Chief Financial Officer and Executive Vice President Bernie Blegen after a decade in executive roles. Long-time Corporate Controller Rob Dean has been promoted to interim CFO, marking an internal succession within the finance team. The leadership change highlights a transition at the top of the company’s financial function while the board considers longer term plans for the role. Monolithic Power Systems focuses on analog...
NYSE:GIS
NYSE:GISFood

General Mills Cuts 2026 Outlook As GLP 1 Trends Reshape Demand

General Mills (NYSE:GIS) has reduced its fiscal 2026 sales outlook, citing weaker consumer demand linked to inflation, reduced food assistance, and geopolitical uncertainty. The company’s CEO has highlighted early effects of GLP-1 weight loss drugs on eating habits, including a tilt toward smaller portions and more nutrient dense foods. These shifts are prompting General Mills to reassess product mix and long term plans across its packaged food portfolio. At a share price of $44.96, General...
NYSE:CNP
NYSE:CNPIntegrated Utilities

A Look At CenterPoint Energy’s Valuation As Grid Upgrades And Q4 2025 Earnings Come Into Focus

CenterPoint Energy (CNP) is in focus as it prepares to report fourth quarter 2025 results on February 19, alongside recent grid upgrades and the launch of its Community Progress Tracker in Greater Houston. See our latest analysis for CenterPoint Energy. Those grid upgrades and the new Community Progress Tracker arrive at a time when momentum in CenterPoint Energy’s share price has been building, with a 30 day share price return of 7.40% and a 1 year total shareholder return of 29.19% from a...
NYSE:LMT
NYSE:LMTAerospace & Defense

How Investors Are Reacting To Lockheed Martin (LMT) Dividend Hike And Nuclear Microreactor Bet

Lockheed Martin recently authorized a first-quarter 2026 dividend of US$3.45 per share and invested in Radiant’s portable nuclear microreactor venture, while its leadership also presented at Citi’s Global Industrial Tech & Mobility Conference in Miami Beach on February 18. Together, the dividend decision and Radiant investment highlight how Lockheed Martin is pairing shareholder income with exposure to emerging defense-related energy technologies. We’ll now examine how Lockheed Martin’s...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

Assessing Enphase Energy (ENPH) Valuation After New Power Control Software Launch

Enphase Energy (ENPH) just rolled out its Power Control software for IQ9 and IQ8 small commercial microinverter systems, a product move that touches on permitting, interconnection costs, and stalled solar projects in California. See our latest analysis for Enphase Energy. The new Power Control launch follows a sharp technical turnaround, with a 30-day share price return of 30.47% and a 90-day share price return of 74.73%. However, the 1-year total shareholder return of 31.22% and 3-year total...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Tempus AI Lung Screening Deal Deepens Role In Clinical Workflows

Tempus AI (NasdaqGS:TEM) announced a collaboration with Median Technologies to integrate eyonis LCS, an FDA cleared AI software for lung cancer screening, into its Tempus Pixel platform. The integration is aimed at supporting lung cancer detection and risk stratification as part of Tempus AI's broader precision medicine and diagnostics offering. For you as an investor, this move sits at the intersection of AI, oncology, and clinical workflows, an area where Tempus AI is already active...
NYSE:PWR
NYSE:PWRConstruction

Is It Too Late To Consider Quanta Services (PWR) After Its Strong Multi‑Year Rally?

If you are wondering whether Quanta Services at around US$525 a share still offers value, you are not alone. This article is designed to help you assess that question clearly. The stock has recorded returns of 2.8% over the last 7 days, 12.5% over the last 30 days, 19.4% year to date and 82.8% over the past year, with a very large 5 year return that is well over 5x the starting point. This naturally raises questions about what is already priced in. Recent headlines around Quanta Services...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

Waystar Integration Of Iodine And AI Recognition Reshape Growth Outlook

Waystar Holding (NasdaqGS:WAY) has rapidly integrated Iodine Software following its acquisition, completing key revenue cycle and clinical intelligence alignment ahead of schedule. The combined platform now reaches a larger hospital client base and is being recognized nationally for its AI driven revenue cycle automation. Waystar was recently named an Inc. Best in Business honoree for AI Implementation, highlighting its role in healthcare revenue cycle automation. Waystar's recent moves...
NYSE:FHI
NYSE:FHICapital Markets

A Look At Federated Hermes (FHI) Valuation As Shares Trade Near Fair Value Estimates

Federated Hermes (FHI) has drawn fresh attention after recent trading left the shares with a reported intrinsic discount of about 13%, prompting investors to reassess the asset manager’s valuation and long term return profile. See our latest analysis for Federated Hermes. Recent trading has been choppy, with the 1 day share price return of Federated Hermes at a 1% decline. However, the 90 day share price return of 14.24% and the 1 year total shareholder return of 46.58% point to building...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Cognex (CGNX) Is Up 32.7% After Earnings Beat, Board Refresh And Completed Buybacks – Has The Bull Case Changed?

Cognex recently reported fourth-quarter 2025 sales of US$252.34 million and full-year sales of US$994.36 million, alongside higher net income and earnings per share, while completing a US$500 million share repurchase program and declaring a quarterly dividend of US$0.085 per share. On top of these capital returns, the Board refreshed its membership by appointing automation and enterprise sales veterans Dr. Sami Atiya and Chris Donato, changes that could influence how Cognex pursues AI-driven...
NYSE:COHR
NYSE:COHRElectronic

A Look At Coherent (COHR) Valuation As Options Activity Jumps Before Earnings And Awards Highlight Optical Strength

Coherent (COHR) is back in focus after a surge in bullish option activity and higher implied volatility ahead of its May 6 earnings report, alongside fresh industry awards for its optical networking products. See our latest analysis for Coherent. After a strong run that includes a 30 day share price return of 15.14% and a 90 day share price return of 53.88%, Coherent’s recent 1 year total shareholder return of 148.04% and 3 year total shareholder return of over 4x suggest momentum has been...
NYSE:MTN
NYSE:MTNHospitality

Did Oasis’ US$122 Million MTN Buy After Weak Ski Season Just Reframe Vail’s Resilience Story?

In the fourth quarter of 2025, Oasis Management disclosed buying 833,500 Vail Resorts shares, lifting its stake by about US$122.66 million despite season-to-date skier visits falling 20% and related lift, ski school, and dining revenues also declining due to below-average snowfall. This sizable purchase by a professional investor, even after a weak ski season, highlights differing views on Vail Resorts’ longer-term business resilience and earnings power. We’ll now examine how Oasis...
NasdaqGS:IPAR
NasdaqGS:IPARPersonal Products

How Investors May Respond To Interparfums (IPAR) Rising Estimates Amid Expectations Of Lower Earnings

Interparfums, the fragrance maker behind brands such as Kate Spade and Abercrombie & Fitch, recently attracted attention after analysts revised earnings estimates higher for the quarter ended December 2025, even as they anticipated earnings would decline year over year on higher revenue. This shift in expectations, alongside the company’s track record of 14.1% annual revenue growth over the past three years and strong returns on invested capital, has reinforced confidence in its ability to...
NasdaqGS:SVRA
NasdaqGS:SVRABiotechs

A Look At Savara (SVRA) Valuation After Recent FDA Progress And Strengthened Outlook

Why Savara’s recent FDA progress is back in focus Savara (SVRA) is back on investor radars after resubmitting its biologics license application, completing a tech transfer to Fujifilm, and aligning key analytical protocols with the FDA. With an FDA filing decision expected in the near term and management expressing strong confidence in the updated package, the upcoming Guggenheim Securities Emerging Outlook, Biotech Summit presentation on February 11 is drawing extra attention from...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

Is LeMaitre Vascular (LMAT) Pricing Too Rich After Mixed Long Term Returns?

If you are wondering whether LeMaitre Vascular at around US$89.25 is priced fairly or not, this article will walk through what the current valuation actually implies for you as a shareholder or potential investor. The stock shows a mix of recent returns, with gains of 1.4% over the last 7 days, 1.1% over 30 days and 11.3% year to date, but a 10.6% decline over 1 year, alongside longer term returns of 85.6% over 3 years and 98.2% over 5 years. Recent news coverage around LeMaitre Vascular has...